Optimizing early-phase immunotherapy trials: the role of biomarker enrichment strategies

by biblioteca on 9 de febrer de 2026 with No hi ha comentaris

Catani, G., Morchón-Araujo, D., Mirallas, O., Sánchez-Pérez, V., Nuciforo, P., Villacampa, G., Dientsmann, R., … Hernando-Calvo, A. (2025). Optimizing early-phase immunotherapy trials: the role of biomarker enrichment strategies. Frontiers In Immunology, 16, Article 1664443. https://doi.org/10.3389/fimmu.2025.1664443